Skip to Content
William Ricke, PhD

Contact Dr. Ricke

E-mail:
rickew@urology.wisc.edu

Phone:
(608) 265-3202

Mail:
Wisconsin Institutes for Medical Research
1111 Highland Avenue
Madison, WI 53705

William Ricke, PhD

Associate Professor

Research Interests

Dr. Ricke’s research interests include prostate cancer.

Recent Publications
  • Bauman TM, Nicholson TM, Abler LL, Eliceiri KW, Huang W, Vezina CM, Ricke WA. Characterization of fibrillar collagens and extracellular matrix of glandular benign prostatic hyperplasia nodules. PLoS ONE 2014; 9(10):e109102.
    [PubMed ID: 25275645, PMCID: 4183548]
    More Information
  • Nicholson TM, Moses MA, Uchtmann KS, Keil KP, Bjorling DE, Vezina CM, Wood RW, Ricke WA. Estrogen receptor-alpha is a key mediator and therapeutic target for bladder complications of benign prostatic hyperplasia. J. Urol. 2014 Aug 25.
    [PubMed ID: 25167991]
    More Information
  • Bauman TM, Sehgal PD, Johnson KA, Pier T, Bruskewitz RC, Ricke WA, Huang W. Finasteride treatment alters tissue specific androgen receptor expression in prostate tissues. Prostate 2014 Jun; 74(9):923-32.
    [PubMed ID: 24789081, PMCID: 4137476]
    More Information
  • Peretz J, Vrooman L, Ricke WA, Hunt PA, Ehrlich S, Hauser R, Padmanabhan V, Taylor HS, Swan SH, VandeVoort CA, Flaws JA. Bisphenol a and reproductive health: update of experimental and human evidence, 2007-2013. Environ. Health Perspect. 2014 Aug; 122(8):775-86.
    [PubMed ID: 24896072, PMCID: 4123031]
    More Information
  • Lewis SR, Hedman CJ, Ziegler T, Ricke WA, Jorgensen JS. Steroidogenic factor 1 promotes aggressive growth of castration-resistant prostate cancer cells by stimulating steroid synthesis and cell proliferation. Endocrinology 2014 Feb; 155(2):358-69.
    [PubMed ID: 24265454, PMCID: 3891934]
    More Information
  • Nicholson TM, Uchtmann KS, Valdez CD, Theberge AB, Miralem T, Ricke WA. Renal capsule xenografting and subcutaneous pellet implantation for the evaluation of prostate carcinogenesis and benign prostatic hyperplasia. J Vis Exp 2013; (78):.
    [PubMed ID: 24022657, PMCID: 3856856]
    More Information
  • Nicholson TM, Sehgal PD, Drew SA, Huang W, Ricke WA. Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment. Differentiation 2013 Apr-Jun; 85(4-5):140-9.
    [PubMed ID: 23792768, PMCID: 3729928]
    More Information
  • Ewald JA, Downs TM, Cetnar JP, Ricke WA. Expression microarray meta-analysis identifies genes associated with Ras/MAPK and related pathways in progression of muscle-invasive bladder transition cell carcinoma. PLoS ONE 2013; 8(2):e55414.
    [PubMed ID: 23383328, PMCID: 3562183]
    More Information
  • Nicholson TM, Ricke EA, Marker PC, Miano JM, Mayer RD, Timms BG, vom Saal FS, Wood RW, Ricke WA. Testosterone and 17β-estradiol induce glandular prostatic growth, bladder outlet obstruction, and voiding dysfunction in male mice. Endocrinology 2012 Nov; 153(11):5556-65.
    [PubMed ID: 22948219, PMCID: 3473198]
    More Information
  • Verdoorn BP, Feng C, Ricke WA, Sahasrabudhe DM, Kilari D, Kohli M. An observational study of plasma vascular endothelial growth factors (VEGF) A and D expression in non-localized prostate cancer. J Mens Health 2012 Sep 1; 9(3):182-189.
    [PubMed ID: 24416090, PMCID: 3886726]
    More Information


webmaster@surgery.wisc.edu Copyright © 2014 The Board of Regents of the University of Wisconsin System